Plain-English translation of NCT07186751 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether combining works better than alone for treating fibromyalgia—a chronic condition that causes widespread pain, fatigue, and mood changes. Right now, by itself only helps about 25–40% of patients get meaningful pain relief. Researchers believe that adding venlafaxine, a medication that affects mood-related brain chemicals, might help more people feel better without causing more side effects.
Many patients with fibromyalgia don't get enough pain relief from current treatments, and doctors are looking for better combinations that work together to address the different causes of this condition.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to take either alone or combined with venlafaxine. The study involves taking daily pills for a set period and attending follow-up visits where doctors will check how well the treatment is working, measure your pain levels, and monitor for any side effects. The trial is enrolling 750 participants across multiple centers, so you'll be part of a large group helping researchers understand which approach works best.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China